Gao-Jun Teng

9PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Animal diet and nutritionGene and molecular therapyComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 10, 2026
Reply to: Different Stage But Similar Survival in Hepatocellular Carcinoma: A Dilemma of Treatment Timing?

|Mar 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma.

Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin

|Feb 24, 2026
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial.

Hai-Dong Zhu, Wei-Jun Fan, Chang Zhao

|Jul 30, 2024
Bariatric arterial embolization slows gastric emptying and improves postprandial glycaemia in obese dogs with impaired glucose tolerance.

Zhi Wang, Qing-Yue Cao, Chunjie Xiang

|Jul 13, 2023
Interventional metabology: A review of bariatric arterial embolization and endovascular denervation for treating metabolic disorders.

Zhi Wang, Dan-Qi Zhu, Xiang-Yun Zhu

|Jun 27, 2023
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study.

Zhi-Cheng Jin, Bin-Yan Zhong, Jian-Jian Chen

Pageof 2

Frequent Collaborators

3 joint publications

Zhi-Cheng Jin

2 joint publications

Hai-Dong Zhu

1 joint publications

Congxiao Wang

1 joint publications

Yi Zhang